Acelyrin Inc

ACELYRIN Inc. is a late-stage clinical biopharmaceuticals specialist. With an active presence in the US, it focuses primarily on transformative medicines. Located in the pharmaceutical arm of the wider healthcare industry, ACELYRIN distinguishes itself from other biopharmaceuticals through its development of izokibep, a small therapeutic protein inhibitor that could treat a wide array of conditions. As a standalone organisation, this product has garnered the company industry recognition. ACELYRIN also has a subsidiary in the form of biotech company ValenzaBio, Inc. Diversify your virtual portfolio by following SLRN shares on eToro.